MCL1 and neuroblastoma: Further analysis demonstrated that the Mcl-1 inhibitor NOXA, encoded by PMAIP1, was significantly higher in N-Myc amplified neuroblastomas suggesting that increased NOXA expression was a contributing factor to ABT-199 sensitivity observed in N-Myc amplified neuroblastoma cells.